188 related articles for article (PubMed ID: 27039175)
1. Characterization of the serum metabolome following radiation treatment in patients with high-grade gliomas.
Mörén L; Wibom C; Bergström P; Johansson M; Antti H; Bergenheim AT
Radiat Oncol; 2016 Apr; 11():51. PubMed ID: 27039175
[TBL] [Abstract][Full Text] [Related]
2. Metabolomic patterns in glioblastoma and changes during radiotherapy: a clinical microdialysis study.
Wibom C; Surowiec I; Mörén L; Bergström P; Johansson M; Antti H; Bergenheim AT
J Proteome Res; 2010 Jun; 9(6):2909-19. PubMed ID: 20302353
[TBL] [Abstract][Full Text] [Related]
3. Radiotherapy induces an immediate inflammatory reaction in malignant glioma: a clinical microdialysis study.
Tabatabaei P; Visse E; Bergström P; Brännström T; Siesjö P; Bergenheim AT
J Neurooncol; 2017 Jan; 131(1):83-92. PubMed ID: 27664151
[TBL] [Abstract][Full Text] [Related]
4. Metabolomic screening of pre-diagnostic serum samples identifies association between α- and γ-tocopherols and glioblastoma risk.
Björkblom B; Wibom C; Jonsson P; Mörén L; Andersson U; Johannesen TB; Langseth H; Antti H; Melin B
Oncotarget; 2016 Jun; 7(24):37043-37053. PubMed ID: 27175595
[TBL] [Abstract][Full Text] [Related]
5. Metabolomic Screening of Tumor Tissue and Serum in Glioma Patients Reveals Diagnostic and Prognostic Information.
Mörén L; Bergenheim AT; Ghasimi S; Brännström T; Johansson M; Antti H
Metabolites; 2015 Sep; 5(3):502-20. PubMed ID: 26389964
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.
Yue X; Lan F; Hu M; Pan Q; Wang Q; Wang J
J Neurosurg; 2016 Jan; 124(1):122-8. PubMed ID: 26230475
[TBL] [Abstract][Full Text] [Related]
7. The clinical value of serum hepatocyte growth factor levels in patients undergoing primary radiotherapy for glioma: effect on progression-free survival.
Liang QL; Mo ZY; Wang P; Li X; Liu ZX; Zhou ZM
Med Oncol; 2014 Sep; 31(9):122. PubMed ID: 25064731
[TBL] [Abstract][Full Text] [Related]
8. Gene expression microarray analysis reveals YKL-40 to be a potential serum marker for malignant character in human glioma.
Tanwar MK; Gilbert MR; Holland EC
Cancer Res; 2002 Aug; 62(15):4364-8. PubMed ID: 12154041
[TBL] [Abstract][Full Text] [Related]
9. Ganglioside GD3 shedding by human gliomas.
Nakamura O; Iwamori M; Matsutani M; Takakura K
Acta Neurochir (Wien); 1991; 109(1-2):34-6. PubMed ID: 1648861
[TBL] [Abstract][Full Text] [Related]
10. Identification of metabolites in plasma for predicting survival in glioblastoma.
Shen J; Song R; Hodges TR; Heimberger AB; Zhao H
Mol Carcinog; 2018 Aug; 57(8):1078-1084. PubMed ID: 29603794
[TBL] [Abstract][Full Text] [Related]
11. [1H-MR Spectroscopy of brain tumors in the course of radiation therapy: Use of fast spectroscopic imaging and single-voxel spectroscopy for diagnosing recurrence].
Träber F; Block W; Flacke S; Lamerichs R; Schüller H; Urbach H; Keller E; Schild HH
Rofo; 2002 Jan; 174(1):33-42. PubMed ID: 11793282
[TBL] [Abstract][Full Text] [Related]
12. Metabolomics of human cerebrospinal fluid identifies signatures of malignant glioma.
Locasale JW; Melman T; Song S; Yang X; Swanson KD; Cantley LC; Wong ET; Asara JM
Mol Cell Proteomics; 2012 Jun; 11(6):M111.014688. PubMed ID: 22240505
[TBL] [Abstract][Full Text] [Related]
13. Radiotherapy for high-grade gliomas. Does altered fractionation improve the outcome?
Nieder C; Andratschke N; Wiedenmann N; Busch R; Grosu AL; Molls M
Strahlenther Onkol; 2004 Jul; 180(7):401-7. PubMed ID: 15241527
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy in supratentorial gliomas. A study of 821 cases.
Heesters M; Molenaar W; Go GK
Strahlenther Onkol; 2003 Sep; 179(9):606-14. PubMed ID: 14628126
[TBL] [Abstract][Full Text] [Related]
15. ADC texture--an imaging biomarker for high-grade glioma?
Brynolfsson P; Nilsson D; Henriksson R; Hauksson J; Karlsson M; Garpebring A; Birgander R; Trygg J; Nyholm T; Asklund T
Med Phys; 2014 Oct; 41(10):101903. PubMed ID: 25281955
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of serial magnetic resonance spectroscopies over the course of radiation therapy for patients with malignant glioma.
Alexander A; Murtha A; Abdulkarim B; Mehta V; Wheatley M; Murray B; Riauka T; Hanson J; Fulton D; McEwan A; Roa W
Clin Invest Med; 2006 Oct; 29(5):301-11. PubMed ID: 17144440
[TBL] [Abstract][Full Text] [Related]
17. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.
Grosu AL; Weber WA; Franz M; Stärk S; Piert M; Thamm R; Gumprecht H; Schwaiger M; Molls M; Nieder C
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):511-9. PubMed ID: 16168843
[TBL] [Abstract][Full Text] [Related]
18. Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas.
Fine HA; Figg WD; Jaeckle K; Wen PY; Kyritsis AP; Loeffler JS; Levin VA; Black PM; Kaplan R; Pluda JM; Yung WK
J Clin Oncol; 2000 Feb; 18(4):708-15. PubMed ID: 10673511
[TBL] [Abstract][Full Text] [Related]
19. Human plasma metabolomics for identifying differential metabolites and predicting molecular subtypes of breast cancer.
Fan Y; Zhou X; Xia TS; Chen Z; Li J; Liu Q; Alolga RN; Chen Y; Lai MD; Li P; Zhu W; Qi LW
Oncotarget; 2016 Mar; 7(9):9925-38. PubMed ID: 26848530
[TBL] [Abstract][Full Text] [Related]
20. Metabolomic profiling of blood plasma in patients with primary brain tumours: Basal plasma metabolites correlated with tumour grade and plasma biomarker analysis predicts feasibility of the successful statistical discrimination from healthy subjects - a preliminary study.
Baranovičová E; Galanda T; Galanda M; Hatok J; Kolarovszki B; Richterová R; Račay P
IUBMB Life; 2019 Dec; 71(12):1994-2002. PubMed ID: 31419008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
